Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Comparing interest in indoor tanning among countries with different tanning bed regulations.

Misitzis A, Weinstock MA, Stratigos AJ.

J Eur Acad Dermatol Venereol. 2019 Dec 31. doi: 10.1111/jdv.16173. [Epub ahead of print]

PMID:
31891430
2.

Pathologists' Agreement on Treatment Suggestions for Melanocytic Skin Lesions.

Jafry MA, Peacock S, Radick AC, Shucard HL, Reisch LM, Piepkorn MW, Knezevich SR, Weinstock MA, Barnhill RL, Elder DE, Kerr KF, Elmore JG.

J Am Acad Dermatol. 2019 Dec 17. pii: S0190-9622(19)33295-5. doi: 10.1016/j.jaad.2019.12.020. [Epub ahead of print]

PMID:
31862403
3.

Keratinocyte Carcinoma Mortality in the United States as Reported in Death Certificates, 2011-2017.

Misitzis A, Beatson M, Weinstock MA.

Dermatol Surg. 2019 Nov 5. doi: 10.1097/DSS.0000000000002261. [Epub ahead of print]

PMID:
31702593
4.

Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.

Beatson M, Siegel JA, Chren MM, Weinstock MA.

Eur J Dermatol. 2019 Oct 1;29(5):507-510. doi: 10.1684/ejd.2019.3637.

PMID:
31647464
5.

Increased interest in sunless tanning versus tanning beds in the United States: A Google Trends analysis.

Misitzis A, Weinstock MA.

J Am Acad Dermatol. 2019 Dec;81(6):1438-1439. doi: 10.1016/j.jaad.2019.06.017. Epub 2019 Jun 13. No abstract available.

PMID:
31629620
6.

The 'Check-It-Out' intervention increases confidence and practices of thorough skin self-examination.

Misitzis A, Kang A, Weinstock MA, Risica PM.

J Eur Acad Dermatol Venereol. 2019 Sep 30. doi: 10.1111/jdv.15969. [Epub ahead of print] No abstract available.

PMID:
31568597
7.

A study on healthcare utilization for actinic keratoses in the Netherlands highlights a global issue.

Misitzis A, Beatson M, Weinstock MA.

Br J Dermatol. 2019 Sep;181(3):441-442. doi: 10.1111/bjd.17862. Epub 2019 Jun 28. No abstract available.

PMID:
31250917
8.

Treatments for primary squamous cell carcinoma and squamous cell carcinoma in situ of the skin: A systematic review and network meta-analysis: Summary of an Agency for Healthcare Research and Quality Comparative Effectiveness Review.

Drucker AM, Adam GP, Rofeberg V, Gazula A, Smith B, Moustafa F, Weinstock MA, Trikalinos TA.

J Am Acad Dermatol. 2020 Feb;82(2):479-482. doi: 10.1016/j.jaad.2019.06.030. Epub 2019 Jun 21. No abstract available.

PMID:
31233858
9.

An increase in sunscreen use in a population resistant to sun protection.

Misitzis A, Beatson M, Siegel JA, Korgavkar K, Walker J, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.

J Am Acad Dermatol. 2019 Dec;81(6):1441-1442. doi: 10.1016/j.jaad.2019.06.020. Epub 2019 Jun 19. No abstract available.

PMID:
31228521
10.

Trends in usage of the terms keratinocyte carcinoma and nonmelanoma skin cancer in the medical literature.

Beatson M, Misitzis A, Lew RA, Weinstock MA.

Br J Dermatol. 2019 Dec;181(6):1308-1309. doi: 10.1111/bjd.18213. Epub 2019 Aug 20. No abstract available.

PMID:
31175660
11.

Identifying a patient cohort responsible for a disproportionate number of lost opportunities for dermatologic care at a Veterans Affairs Medical Center.

Zhou J, Weinstock MA, Done N, Landow SM.

J Am Acad Dermatol. 2019 Dec;81(6):1412-1414. doi: 10.1016/j.jaad.2019.05.026. Epub 2019 May 16. No abstract available.

PMID:
31103571
12.

Counting keratinocyte carcinomas as a step to preventing them.

Beatson M, Misitzis A, Weinstock MA.

J Am Acad Dermatol. 2019 Oct;81(4):1030-1031. doi: 10.1016/j.jaad.2019.03.071. Epub 2019 Mar 30. No abstract available.

PMID:
30935987
13.

Response to: A randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization.

Misitzis A, Beatson M, Weinstock MA.

Int J Dermatol. 2019 Oct;58(10):e185-e186. doi: 10.1111/ijd.14449. Epub 2019 Mar 27. No abstract available.

PMID:
30916781
14.

Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.

Beatson M, Means AD, Leader NF, Robinson-Bostom L, Weinstock MA.

Acta Derm Venereol. 2019 Jun 1;99(7):707-708. doi: 10.2340/00015555-3176. No abstract available.

15.

Teledermatology Outcomes in the Providence Veterans Health Administration.

Bertrand SE, Weinstock MA, Landow SM.

Telemed J E Health. 2019 Dec;25(12):1183-1188. doi: 10.1089/tmj.2018.0242. Epub 2019 Feb 12.

PMID:
30758254
16.

Further Consideration of the Pigmented Lesion Assay.

Beatson M, Weinstock MA.

JAMA Dermatol. 2019 Mar 1;155(3):393. doi: 10.1001/jamadermatol.2018.5478. No abstract available.

PMID:
30698618
17.

Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.

Siegel JA, Beatson M, Chren MM, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group.

J Am Acad Dermatol. 2019 May;80(5):1458-1459. doi: 10.1016/j.jaad.2018.12.054. Epub 2019 Jan 11. No abstract available.

PMID:
30639882
18.

Cutaneous nevi and risk of melanoma death in women and men: A prospective study.

Li WQ, Cho E, Weinstock MA, Li S, Stampfer MJ, Qureshi AA.

J Am Acad Dermatol. 2019 May;80(5):1284-1291. doi: 10.1016/j.jaad.2018.12.058. Epub 2019 Jan 11.

PMID:
30639880
19.

Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.

Drucker AM, Li WQ, Savitz DA, Weinstock MA, Han J, Li T, Qureshi AA, Cho E.

JAMA Dermatol. 2019 Mar 1;155(3):353-357. doi: 10.1001/jamadermatol.2018.4216.

20.

Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual.

Elmore JG, Elder DE, Barnhill RL, Knezevich SR, Longton GM, Titus LJ, Weinstock MA, Pepe MS, Nelson HD, Reisch LM, Radick AC, Piepkorn MW.

JAMA Netw Open. 2018 May;1(1). pii: e180083. doi: 10.1001/jamanetworkopen.2018.0083.

21.

VA Telederm study: protocol for a stepped-wedge cluster randomised trial to compare access to care for a mobile app versus a workstation-based store-and-forward teledermatology process.

Done N, Oh DH, Weinstock MA, Whited JD, Jackson GL, King HA, Peracca SB, Elwy AR, Prentice JC.

BMJ Open. 2018 Dec 14;8(12):e022218. doi: 10.1136/bmjopen-2018-022218.

22.

Development of a Pigmented Facial Lesion Scale Based on Darkness and Extent of Lesions in Older Veterans.

Means AD, Lee KC, Korgavkar K, Swetter SM, Dellavalle RP, Chen S, Stricklin G, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group.

J Invest Dermatol. 2019 May;139(5):1185-1187. doi: 10.1016/j.jid.2018.11.017. Epub 2018 Nov 30. No abstract available.

PMID:
30508548
23.

Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study.

Higgins HW 2nd, Cho E, Weinstock MA, Li TY, Qureshi A, Li WQ.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1268-1271. doi: 10.1111/jdv.15348. Epub 2018 Dec 5.

PMID:
30451319
24.

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Review. Erratum in: Cancer. 2019 Aug 1;125(15):2706.

25.

Treatments of Primary Basal Cell Carcinoma of the Skin: A Systematic Review and Network Meta-analysis.

Drucker AM, Adam GP, Rofeberg V, Gazula A, Smith B, Moustafa F, Weinstock MA, Trikalinos TA.

Ann Intern Med. 2018 Oct 2;169(7):456-466. doi: 10.7326/M18-0678. Epub 2018 Sep 18.

PMID:
30242379
26.

Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey.

Matthews NH, Risica PM, Ferris LK, Beatson M, Saul M, Geller AC, Solano F, Kirkwood JM, Weinstock MA.

Br J Dermatol. 2019 Mar;180(3):664-665. doi: 10.1111/bjd.17134. Epub 2018 Oct 23. No abstract available.

PMID:
30183068
27.

Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.

Onega T, Barnhill RL, Piepkorn MW, Longton GM, Elder DE, Weinstock MA, Knezevich SR, Reisch LM, Carney PA, Nelson HD, Radick AC, Elmore JG.

JAMA Dermatol. 2018 Oct 1;154(10):1159-1166. doi: 10.1001/jamadermatol.2018.2388.

28.

Assessment of the Safety Risk of Dermatoscope Magnets in Patients With Cardiovascular Implanted Electronic Devices.

Rishpon A, Braun R, Weinstock MA, Kulju S, Grenga A, Navarrete-Dechent C, Marghoob NG, Steffel J, Marghoob AA.

JAMA Dermatol. 2018 Oct 1;154(10):1204-1207. doi: 10.1001/jamadermatol.2018.2531.

29.

Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions.

Titus LJ, Reisch LM, Tosteson ANA, Nelson HD, Frederick PD, Carney PA, Barnhill RL, Elder DE, Weinstock MA, Piepkorn MW, Elmore JG.

Am J Clin Pathol. 2018 Aug 30;150(4):338-345. doi: 10.1093/ajcp/aqy057.

30.

Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.

Weinstock MA, Lew RA, Shaw FM; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.

JAMA Dermatol. 2018 Jul 1;154(7):851-852. doi: 10.1001/jamadermatol.2018.1230. No abstract available.

PMID:
29898230
31.

Psychosocial consequences of skin cancer screening.

Risica PM, Matthews NH, Dionne L, Mello J, Ferris LK, Saul M, Geller AC, Solano F, Kirkwood JM, Weinstock MA.

Prev Med Rep. 2018 Apr 17;10:310-316. doi: 10.1016/j.pmedr.2018.04.011. eCollection 2018 Jun.

32.

Complexities of perceived and actual performance in pathology interpretation: A comparison of cutaneous melanocytic skin and breast interpretations.

Carney PA, Frederick PD, Reisch LM, Titus L, Knezevich SR, Weinstock MA, Piepkorn MW, Barnhill RL, Elder DE, Weaver DL, Elmore JG.

J Cutan Pathol. 2018 Jul;45(7):478-490. doi: 10.1111/cup.13147. Epub 2018 Apr 26.

33.

How data can deliver for dermatology.

Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM; Epidemiology Expert Research Group.

J Am Acad Dermatol. 2018 Aug;79(2):400-402. doi: 10.1016/j.jaad.2018.03.020. Epub 2018 Mar 21. No abstract available.

34.

Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin [Internet].

Drucker A, Adam GP, Langberg V, Gazula A, Smith B, Moustafa F, Weinstock MA, Trikalinos TA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec.

35.

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Jul;79(1):52-59.e5. doi: 10.1016/j.jaad.2018.02.070. Epub 2018 Mar 7.

36.

Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.

Yoon J, Phibbs CS, Chow A, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.

J Am Acad Dermatol. 2018 Sep;79(3):501-507.e2. doi: 10.1016/j.jaad.2018.02.058. Epub 2018 Mar 2.

PMID:
29505863
37.

Epidemiology of Melanoma.

Matthews NH, Li WQ, Qureshi AA, Weinstock MA, Cho E.

In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 1.

38.

Comparing Topical Treatments for Basal Cell Carcinoma.

Shaw FM, Weinstock MA.

J Invest Dermatol. 2018 Mar;138(3):484-486. doi: 10.1016/j.jid.2017.11.024. Epub 2018 Feb 1.

39.

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.

Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, Means AD, Leader NF, Shaw FM, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin GP, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri JE, Robinson-Bostom L, Ringer RJ, Lew RA, Ferguson R, DiGiovanna JJ, Huang GD; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.

JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.

40.

Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas.

Leader NF, Means AD, Robinson-Bostom L, Telang GH, Wilkel CS, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group.

J Am Acad Dermatol. 2018 Jan;78(1):185-187. doi: 10.1016/j.jaad.2017.07.024. No abstract available.

PMID:
29241779
41.

A risk adjustment approach to estimating the burden of skin disease in the United States.

Lim HW, Collins SAB, Resneck JS Jr, Bolognia J, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Begolka WS, Moyano JV.

J Am Acad Dermatol. 2018 Jan;78(1):129-140. doi: 10.1016/j.jaad.2017.08.060. Epub 2017 Oct 27.

PMID:
29110889
42.

Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.

Lott JP, Boudreau DM, Barnhill RL, Weinstock MA, Knopp E, Piepkorn MW, Elder DE, Knezevich SR, Baer A, Tosteson ANA, Elmore JG.

JAMA Dermatol. 2018 Jan 1;154(1):24-29. doi: 10.1001/jamadermatol.2017.4060.

43.

Tetracycline use and risk of incident skin cancer: a prospective study.

Li WQ, Drucker AM, Cho E, Laden F, VoPham T, Li S, Weinstock MA, Qureshi AA.

Br J Cancer. 2018 Jan;118(2):294-298. doi: 10.1038/bjc.2017.378. Epub 2017 Oct 26.

44.

Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial.

Korgavkar K, Lee KC, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group.

JAMA Dermatol. 2017 Nov 1;153(11):1142-1146. doi: 10.1001/jamadermatol.2017.2578.

45.

Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.

46.

Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.

Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A.

Eur J Cancer Prev. 2018 Nov;27(6):563-569. doi: 10.1097/CEJ.0000000000000392.

PMID:
28692584
47.

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.

48.

Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.

Pomerantz H, Chren MM, Lew R, Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*.

Clin Exp Dermatol. 2017 Jul;42(5):488-495. doi: 10.1111/ced.13089.

PMID:
28621489
49.

Reply to: "Inaccuracies in SEER registry data on melanoma thickness".

Landow SM, Gjelsvik A, Weinstock MA.

J Am Acad Dermatol. 2017 Jul;77(1):e19. doi: 10.1016/j.jaad.2017.03.008. No abstract available.

PMID:
28619573
50.

Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.

Swetter SM, Chang J, Shaub AR, Weinstock MA, Lewis ET, Asch SM.

JAMA Dermatol. 2017 Aug 1;153(8):797-801. doi: 10.1001/jamadermatol.2017.1324.

Supplemental Content

Loading ...
Support Center